nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—Fluorouracil—colon cancer	0.243	0.356	CbGbCtD
Montelukast—CYP2C9—Capecitabine—colon cancer	0.141	0.207	CbGbCtD
Montelukast—CYP2C8—Fluorouracil—colon cancer	0.12	0.176	CbGbCtD
Montelukast—CYP2C9—Fluorouracil—colon cancer	0.0837	0.123	CbGbCtD
Montelukast—CYP3A4—Irinotecan—colon cancer	0.0507	0.0742	CbGbCtD
Montelukast—CYP3A4—Vincristine—colon cancer	0.0443	0.0649	CbGbCtD
Montelukast—CYSLTR1—smooth muscle tissue—colon cancer	0.00698	0.0827	CbGeAlD
Montelukast—CYSLTR1—lymphoid tissue—colon cancer	0.00558	0.0661	CbGeAlD
Montelukast—CYSLTR1—bone marrow—colon cancer	0.00508	0.0602	CbGeAlD
Montelukast—CYSLTR1—vagina—colon cancer	0.00487	0.0576	CbGeAlD
Montelukast—Hepatitis cholestatic—Capecitabine—colon cancer	0.00439	0.0189	CcSEcCtD
Montelukast—ALOX5—smooth muscle tissue—colon cancer	0.00423	0.0501	CbGeAlD
Montelukast—PTGS1—endothelium—colon cancer	0.00392	0.0464	CbGeAlD
Montelukast—PTGS1—blood vessel—colon cancer	0.00362	0.0428	CbGeAlD
Montelukast—ALOX5—lymphoid tissue—colon cancer	0.00338	0.04	CbGeAlD
Montelukast—ALOX5—digestive system—colon cancer	0.00334	0.0395	CbGeAlD
Montelukast—CYSLTR1—lymph node—colon cancer	0.00315	0.0373	CbGeAlD
Montelukast—SLCO2B1—renal system—colon cancer	0.00313	0.0371	CbGeAlD
Montelukast—ALOX5—bone marrow—colon cancer	0.00308	0.0364	CbGeAlD
Montelukast—Leukocytoclastic vasculitis—Methotrexate—colon cancer	0.00269	0.0116	CcSEcCtD
Montelukast—CYP2A6—vagina—colon cancer	0.0026	0.0308	CbGeAlD
Montelukast—SLCO2B1—digestive system—colon cancer	0.00257	0.0304	CbGeAlD
Montelukast—Neuropathy—Vincristine—colon cancer	0.00255	0.011	CcSEcCtD
Montelukast—ALOX5—liver—colon cancer	0.00249	0.0294	CbGeAlD
Montelukast—Laryngitis—Capecitabine—colon cancer	0.00245	0.0106	CcSEcCtD
Montelukast—Otitis media—Capecitabine—colon cancer	0.00227	0.00978	CcSEcCtD
Montelukast—Memory impairment—Capecitabine—colon cancer	0.00225	0.0097	CcSEcCtD
Montelukast—CYP2A6—liver—colon cancer	0.00219	0.026	CbGeAlD
Montelukast—Rhinorrhoea—Capecitabine—colon cancer	0.00218	0.0094	CcSEcCtD
Montelukast—Injury—Irinotecan—colon cancer	0.00209	0.00899	CcSEcCtD
Montelukast—Disorientation—Fluorouracil—colon cancer	0.00205	0.00885	CcSEcCtD
Montelukast—Contusion—Capecitabine—colon cancer	0.00203	0.00873	CcSEcCtD
Montelukast—CYP2C8—renal system—colon cancer	0.00201	0.0238	CbGeAlD
Montelukast—Liver disorder—Methotrexate—colon cancer	0.00193	0.00832	CcSEcCtD
Montelukast—SLCO2B1—liver—colon cancer	0.00191	0.0227	CbGeAlD
Montelukast—ALOX5—lymph node—colon cancer	0.00191	0.0226	CbGeAlD
Montelukast—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00177	0.00764	CcSEcCtD
Montelukast—PTGS1—epithelium—colon cancer	0.00176	0.0209	CbGeAlD
Montelukast—Irritability—Fluorouracil—colon cancer	0.00175	0.00755	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00173	0.00744	CcSEcCtD
Montelukast—Cramp muscle—Irinotecan—colon cancer	0.00173	0.00744	CcSEcCtD
Montelukast—PTGS1—smooth muscle tissue—colon cancer	0.0017	0.0201	CbGeAlD
Montelukast—Neuropathy—Capecitabine—colon cancer	0.00166	0.00715	CcSEcCtD
Montelukast—Nasopharyngitis—Fluorouracil—colon cancer	0.00164	0.00708	CcSEcCtD
Montelukast—PTGS1—renal system—colon cancer	0.00163	0.0193	CbGeAlD
Montelukast—Pancreatitis—Irinotecan—colon cancer	0.00163	0.007	CcSEcCtD
Montelukast—Eosinophilia—Fluorouracil—colon cancer	0.00157	0.00677	CcSEcCtD
Montelukast—Upper respiratory tract infection—Irinotecan—colon cancer	0.00154	0.00664	CcSEcCtD
Montelukast—Pneumonia—Vincristine—colon cancer	0.00153	0.00658	CcSEcCtD
Montelukast—Ear pain—Capecitabine—colon cancer	0.00151	0.00648	CcSEcCtD
Montelukast—Neuropathy peripheral—Vincristine—colon cancer	0.00149	0.00641	CcSEcCtD
Montelukast—Pneumonia—Irinotecan—colon cancer	0.00149	0.0064	CcSEcCtD
Montelukast—Sleep disorder—Capecitabine—colon cancer	0.00148	0.00639	CcSEcCtD
Montelukast—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00148	0.00636	CcSEcCtD
Montelukast—SLCO2B1—lymph node—colon cancer	0.00147	0.0174	CbGeAlD
Montelukast—CYP2C9—digestive system—colon cancer	0.00147	0.0174	CbGeAlD
Montelukast—CYP2C8—vagina—colon cancer	0.00146	0.0173	CbGeAlD
Montelukast—Bone disorder—Methotrexate—colon cancer	0.00146	0.00628	CcSEcCtD
Montelukast—Gastroenteritis—Capecitabine—colon cancer	0.00145	0.00624	CcSEcCtD
Montelukast—Jaundice—Irinotecan—colon cancer	0.00144	0.00621	CcSEcCtD
Montelukast—Pneumonia—Fluorouracil—colon cancer	0.00142	0.00613	CcSEcCtD
Montelukast—Infestation—Fluorouracil—colon cancer	0.00142	0.0061	CcSEcCtD
Montelukast—Infestation NOS—Fluorouracil—colon cancer	0.00142	0.0061	CcSEcCtD
Montelukast—Neuropathy peripheral—Fluorouracil—colon cancer	0.00139	0.00598	CcSEcCtD
Montelukast—Conjunctivitis—Fluorouracil—colon cancer	0.00138	0.00593	CcSEcCtD
Montelukast—CYP3A4—renal system—colon cancer	0.00136	0.0162	CbGeAlD
Montelukast—Hypoaesthesia—Vincristine—colon cancer	0.00136	0.00584	CcSEcCtD
Montelukast—Hallucination—Vincristine—colon cancer	0.00136	0.00584	CcSEcCtD
Montelukast—Thirst—Capecitabine—colon cancer	0.00135	0.00581	CcSEcCtD
Montelukast—Vasculitis—Methotrexate—colon cancer	0.00135	0.00581	CcSEcCtD
Montelukast—Urinary tract disorder—Vincristine—colon cancer	0.00135	0.0058	CcSEcCtD
Montelukast—PTGS1—digestive system—colon cancer	0.00134	0.0159	CbGeAlD
Montelukast—Connective tissue disorder—Vincristine—colon cancer	0.00134	0.00577	CcSEcCtD
Montelukast—Urethral disorder—Vincristine—colon cancer	0.00134	0.00575	CcSEcCtD
Montelukast—Epistaxis—Fluorouracil—colon cancer	0.00134	0.00575	CcSEcCtD
Montelukast—Rhinitis—Irinotecan—colon cancer	0.00133	0.00573	CcSEcCtD
Montelukast—Sinusitis—Fluorouracil—colon cancer	0.00133	0.00572	CcSEcCtD
Montelukast—Connective tissue disorder—Irinotecan—colon cancer	0.0013	0.00562	CcSEcCtD
Montelukast—Rhinitis—Fluorouracil—colon cancer	0.00127	0.00549	CcSEcCtD
Montelukast—Cardiac disorder—Vincristine—colon cancer	0.00127	0.00545	CcSEcCtD
Montelukast—Hypoaesthesia—Fluorouracil—colon cancer	0.00127	0.00545	CcSEcCtD
Montelukast—Pharyngitis—Fluorouracil—colon cancer	0.00126	0.00543	CcSEcCtD
Montelukast—Cardiac disorder—Irinotecan—colon cancer	0.00123	0.0053	CcSEcCtD
Montelukast—CYP2C8—liver—colon cancer	0.00123	0.0146	CbGeAlD
Montelukast—Mediastinal disorder—Vincristine—colon cancer	0.00123	0.00529	CcSEcCtD
Montelukast—Irritability—Capecitabine—colon cancer	0.00123	0.00528	CcSEcCtD
Montelukast—Immune system disorder—Irinotecan—colon cancer	0.0012	0.00516	CcSEcCtD
Montelukast—Mediastinal disorder—Irinotecan—colon cancer	0.0012	0.00515	CcSEcCtD
Montelukast—Mental disorder—Vincristine—colon cancer	0.00119	0.00514	CcSEcCtD
Montelukast—PTGS1—vagina—colon cancer	0.00118	0.014	CbGeAlD
Montelukast—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00116	0.00498	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00116	0.00498	CcSEcCtD
Montelukast—Nasopharyngitis—Capecitabine—colon cancer	0.00115	0.00494	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00113	0.00488	CcSEcCtD
Montelukast—CYP3A4—digestive system—colon cancer	0.00112	0.0132	CbGeAlD
Montelukast—Muscle spasms—Irinotecan—colon cancer	0.00111	0.00478	CcSEcCtD
Montelukast—Asthma—Capecitabine—colon cancer	0.00111	0.00478	CcSEcCtD
Montelukast—Influenza—Capecitabine—colon cancer	0.00111	0.00478	CcSEcCtD
Montelukast—CYP2C9—liver—colon cancer	0.00109	0.0129	CbGeAlD
Montelukast—Agitation—Vincristine—colon cancer	0.00109	0.00469	CcSEcCtD
Montelukast—Bronchitis—Capecitabine—colon cancer	0.00107	0.0046	CcSEcCtD
Montelukast—Upper respiratory tract infection—Capecitabine—colon cancer	0.00103	0.00444	CcSEcCtD
Montelukast—Convulsion—Vincristine—colon cancer	0.00103	0.00443	CcSEcCtD
Montelukast—Myalgia—Vincristine—colon cancer	0.00101	0.00435	CcSEcCtD
Montelukast—Cough—Irinotecan—colon cancer	0.00101	0.00434	CcSEcCtD
Montelukast—Pneumonia—Capecitabine—colon cancer	0.000995	0.00429	CcSEcCtD
Montelukast—Infestation NOS—Capecitabine—colon cancer	0.00099	0.00426	CcSEcCtD
Montelukast—Infestation—Capecitabine—colon cancer	0.00099	0.00426	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000981	0.00422	CcSEcCtD
Montelukast—Neuropathy peripheral—Capecitabine—colon cancer	0.00097	0.00418	CcSEcCtD
Montelukast—Anaphylactic shock—Vincristine—colon cancer	0.000968	0.00417	CcSEcCtD
Montelukast—Oedema—Vincristine—colon cancer	0.000968	0.00417	CcSEcCtD
Montelukast—Jaundice—Capecitabine—colon cancer	0.000965	0.00415	CcSEcCtD
Montelukast—Infection—Vincristine—colon cancer	0.000962	0.00414	CcSEcCtD
Montelukast—Conjunctivitis—Capecitabine—colon cancer	0.000962	0.00414	CcSEcCtD
Montelukast—Convulsion—Fluorouracil—colon cancer	0.000959	0.00413	CcSEcCtD
Montelukast—Nervous system disorder—Vincristine—colon cancer	0.00095	0.00409	CcSEcCtD
Montelukast—Thrombocytopenia—Vincristine—colon cancer	0.000948	0.00408	CcSEcCtD
Montelukast—Anaphylactic shock—Irinotecan—colon cancer	0.000943	0.00406	CcSEcCtD
Montelukast—Oedema—Irinotecan—colon cancer	0.000943	0.00406	CcSEcCtD
Montelukast—Myalgia—Fluorouracil—colon cancer	0.000942	0.00406	CcSEcCtD
Montelukast—Infection—Irinotecan—colon cancer	0.000937	0.00403	CcSEcCtD
Montelukast—Hepatobiliary disease—Capecitabine—colon cancer	0.000936	0.00403	CcSEcCtD
Montelukast—Epistaxis—Capecitabine—colon cancer	0.000934	0.00402	CcSEcCtD
Montelukast—Nervous system disorder—Irinotecan—colon cancer	0.000925	0.00398	CcSEcCtD
Montelukast—Thrombocytopenia—Irinotecan—colon cancer	0.000923	0.00398	CcSEcCtD
Montelukast—Irritability—Methotrexate—colon cancer	0.000913	0.00393	CcSEcCtD
Montelukast—Oedema—Fluorouracil—colon cancer	0.000903	0.00389	CcSEcCtD
Montelukast—Anaphylactic shock—Fluorouracil—colon cancer	0.000903	0.00389	CcSEcCtD
Montelukast—Infection—Fluorouracil—colon cancer	0.000897	0.00386	CcSEcCtD
Montelukast—Rhinitis—Capecitabine—colon cancer	0.000891	0.00383	CcSEcCtD
Montelukast—Hepatitis—Capecitabine—colon cancer	0.000889	0.00383	CcSEcCtD
Montelukast—Nervous system disorder—Fluorouracil—colon cancer	0.000886	0.00381	CcSEcCtD
Montelukast—Thrombocytopenia—Fluorouracil—colon cancer	0.000884	0.00381	CcSEcCtD
Montelukast—Hypoaesthesia—Capecitabine—colon cancer	0.000884	0.00381	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Vincristine—colon cancer	0.000882	0.0038	CcSEcCtD
Montelukast—Pharyngitis—Capecitabine—colon cancer	0.000882	0.0038	CcSEcCtD
Montelukast—Urinary tract disorder—Capecitabine—colon cancer	0.000877	0.00378	CcSEcCtD
Montelukast—Insomnia—Vincristine—colon cancer	0.000876	0.00377	CcSEcCtD
Montelukast—Connective tissue disorder—Capecitabine—colon cancer	0.000873	0.00376	CcSEcCtD
Montelukast—Urethral disorder—Capecitabine—colon cancer	0.000871	0.00375	CcSEcCtD
Montelukast—Paraesthesia—Vincristine—colon cancer	0.00087	0.00374	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000861	0.00371	CcSEcCtD
Montelukast—Insomnia—Irinotecan—colon cancer	0.000853	0.00367	CcSEcCtD
Montelukast—Paraesthesia—Irinotecan—colon cancer	0.000847	0.00365	CcSEcCtD
Montelukast—Erythema multiforme—Capecitabine—colon cancer	0.00084	0.00362	CcSEcCtD
Montelukast—Somnolence—Irinotecan—colon cancer	0.000838	0.00361	CcSEcCtD
Montelukast—Gastrointestinal disorder—Vincristine—colon cancer	0.000836	0.0036	CcSEcCtD
Montelukast—Fatigue—Vincristine—colon cancer	0.000835	0.00359	CcSEcCtD
Montelukast—CYP3A4—liver—colon cancer	0.000834	0.00987	CbGeAlD
Montelukast—Dyspepsia—Irinotecan—colon cancer	0.00083	0.00357	CcSEcCtD
Montelukast—Pain—Vincristine—colon cancer	0.000828	0.00357	CcSEcCtD
Montelukast—Asthma—Methotrexate—colon cancer	0.000826	0.00356	CcSEcCtD
Montelukast—Cardiac disorder—Capecitabine—colon cancer	0.000825	0.00355	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000823	0.00354	CcSEcCtD
Montelukast—Eosinophilia—Methotrexate—colon cancer	0.000818	0.00352	CcSEcCtD
Montelukast—Insomnia—Fluorouracil—colon cancer	0.000817	0.00352	CcSEcCtD
Montelukast—Gastrointestinal disorder—Irinotecan—colon cancer	0.000814	0.00351	CcSEcCtD
Montelukast—Fatigue—Irinotecan—colon cancer	0.000813	0.0035	CcSEcCtD
Montelukast—Paraesthesia—Fluorouracil—colon cancer	0.000811	0.00349	CcSEcCtD
Montelukast—Pancreatitis—Methotrexate—colon cancer	0.00081	0.00349	CcSEcCtD
Montelukast—Pain—Irinotecan—colon cancer	0.000807	0.00347	CcSEcCtD
Montelukast—Somnolence—Fluorouracil—colon cancer	0.000803	0.00346	CcSEcCtD
Montelukast—Immune system disorder—Capecitabine—colon cancer	0.000803	0.00346	CcSEcCtD
Montelukast—Mediastinal disorder—Capecitabine—colon cancer	0.000801	0.00345	CcSEcCtD
Montelukast—Dyspepsia—Fluorouracil—colon cancer	0.000795	0.00342	CcSEcCtD
Montelukast—Gastrointestinal pain—Vincristine—colon cancer	0.000792	0.00341	CcSEcCtD
Montelukast—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00078	0.00336	CcSEcCtD
Montelukast—Mental disorder—Capecitabine—colon cancer	0.000778	0.00335	CcSEcCtD
Montelukast—Pain—Fluorouracil—colon cancer	0.000772	0.00333	CcSEcCtD
Montelukast—Gastrointestinal pain—Irinotecan—colon cancer	0.000771	0.00332	CcSEcCtD
Montelukast—Upper respiratory tract infection—Methotrexate—colon cancer	0.000768	0.00331	CcSEcCtD
Montelukast—Abdominal pain—Vincristine—colon cancer	0.000766	0.0033	CcSEcCtD
Montelukast—Body temperature increased—Vincristine—colon cancer	0.000766	0.0033	CcSEcCtD
Montelukast—PTGS1—lymph node—colon cancer	0.000765	0.00906	CbGeAlD
Montelukast—Abdominal pain—Irinotecan—colon cancer	0.000746	0.00321	CcSEcCtD
Montelukast—Body temperature increased—Irinotecan—colon cancer	0.000746	0.00321	CcSEcCtD
Montelukast—Muscle spasms—Capecitabine—colon cancer	0.000744	0.0032	CcSEcCtD
Montelukast—Pneumonia—Methotrexate—colon cancer	0.000741	0.00319	CcSEcCtD
Montelukast—Infestation—Methotrexate—colon cancer	0.000737	0.00317	CcSEcCtD
Montelukast—Infestation NOS—Methotrexate—colon cancer	0.000737	0.00317	CcSEcCtD
Montelukast—Drowsiness—Methotrexate—colon cancer	0.000737	0.00317	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00073	0.00314	CcSEcCtD
Montelukast—Tremor—Capecitabine—colon cancer	0.000725	0.00312	CcSEcCtD
Montelukast—Urticaria—Fluorouracil—colon cancer	0.000718	0.00309	CcSEcCtD
Montelukast—Conjunctivitis—Methotrexate—colon cancer	0.000716	0.00308	CcSEcCtD
Montelukast—Body temperature increased—Fluorouracil—colon cancer	0.000714	0.00307	CcSEcCtD
Montelukast—Hypersensitivity—Vincristine—colon cancer	0.000714	0.00307	CcSEcCtD
Montelukast—Hepatobiliary disease—Methotrexate—colon cancer	0.000697	0.003	CcSEcCtD
Montelukast—Epistaxis—Methotrexate—colon cancer	0.000695	0.00299	CcSEcCtD
Montelukast—Hypersensitivity—Irinotecan—colon cancer	0.000695	0.00299	CcSEcCtD
Montelukast—Asthenia—Vincristine—colon cancer	0.000695	0.00299	CcSEcCtD
Montelukast—Palpitations—Capecitabine—colon cancer	0.000684	0.00294	CcSEcCtD
Montelukast—Asthenia—Irinotecan—colon cancer	0.000677	0.00291	CcSEcCtD
Montelukast—Cough—Capecitabine—colon cancer	0.000675	0.00291	CcSEcCtD
Montelukast—Hypersensitivity—Fluorouracil—colon cancer	0.000666	0.00287	CcSEcCtD
Montelukast—Diarrhoea—Vincristine—colon cancer	0.000663	0.00285	CcSEcCtD
Montelukast—Hepatitis—Methotrexate—colon cancer	0.000661	0.00285	CcSEcCtD
Montelukast—Arthralgia—Capecitabine—colon cancer	0.000658	0.00283	CcSEcCtD
Montelukast—Myalgia—Capecitabine—colon cancer	0.000658	0.00283	CcSEcCtD
Montelukast—Pharyngitis—Methotrexate—colon cancer	0.000656	0.00283	CcSEcCtD
Montelukast—Anxiety—Capecitabine—colon cancer	0.000656	0.00283	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000654	0.00282	CcSEcCtD
Montelukast—Urinary tract disorder—Methotrexate—colon cancer	0.000653	0.00281	CcSEcCtD
Montelukast—Urethral disorder—Methotrexate—colon cancer	0.000648	0.00279	CcSEcCtD
Montelukast—Diarrhoea—Irinotecan—colon cancer	0.000645	0.00278	CcSEcCtD
Montelukast—Dizziness—Vincristine—colon cancer	0.00064	0.00276	CcSEcCtD
Montelukast—Pruritus—Fluorouracil—colon cancer	0.000639	0.00275	CcSEcCtD
Montelukast—Oedema—Capecitabine—colon cancer	0.000631	0.00272	CcSEcCtD
Montelukast—Infection—Capecitabine—colon cancer	0.000627	0.0027	CcSEcCtD
Montelukast—Erythema multiforme—Methotrexate—colon cancer	0.000625	0.00269	CcSEcCtD
Montelukast—Dizziness—Irinotecan—colon cancer	0.000624	0.00269	CcSEcCtD
Montelukast—Nervous system disorder—Capecitabine—colon cancer	0.000619	0.00267	CcSEcCtD
Montelukast—Diarrhoea—Fluorouracil—colon cancer	0.000618	0.00266	CcSEcCtD
Montelukast—Thrombocytopenia—Capecitabine—colon cancer	0.000618	0.00266	CcSEcCtD
Montelukast—Vomiting—Vincristine—colon cancer	0.000616	0.00265	CcSEcCtD
Montelukast—Cardiac disorder—Methotrexate—colon cancer	0.000614	0.00264	CcSEcCtD
Montelukast—Skin disorder—Capecitabine—colon cancer	0.000613	0.00264	CcSEcCtD
Montelukast—Rash—Vincristine—colon cancer	0.000611	0.00263	CcSEcCtD
Montelukast—Dermatitis—Vincristine—colon cancer	0.00061	0.00263	CcSEcCtD
Montelukast—Headache—Vincristine—colon cancer	0.000607	0.00261	CcSEcCtD
Montelukast—Vomiting—Irinotecan—colon cancer	0.0006	0.00258	CcSEcCtD
Montelukast—Immune system disorder—Methotrexate—colon cancer	0.000597	0.00257	CcSEcCtD
Montelukast—Dizziness—Fluorouracil—colon cancer	0.000597	0.00257	CcSEcCtD
Montelukast—Mediastinal disorder—Methotrexate—colon cancer	0.000596	0.00257	CcSEcCtD
Montelukast—Rash—Irinotecan—colon cancer	0.000595	0.00256	CcSEcCtD
Montelukast—Dermatitis—Irinotecan—colon cancer	0.000594	0.00256	CcSEcCtD
Montelukast—Headache—Irinotecan—colon cancer	0.000591	0.00254	CcSEcCtD
Montelukast—Mental disorder—Methotrexate—colon cancer	0.000579	0.00249	CcSEcCtD
Montelukast—Nausea—Vincristine—colon cancer	0.000575	0.00248	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000575	0.00248	CcSEcCtD
Montelukast—Vomiting—Fluorouracil—colon cancer	0.000574	0.00247	CcSEcCtD
Montelukast—Insomnia—Capecitabine—colon cancer	0.000571	0.00246	CcSEcCtD
Montelukast—Rash—Fluorouracil—colon cancer	0.00057	0.00245	CcSEcCtD
Montelukast—Dermatitis—Fluorouracil—colon cancer	0.000569	0.00245	CcSEcCtD
Montelukast—Paraesthesia—Capecitabine—colon cancer	0.000567	0.00244	CcSEcCtD
Montelukast—Headache—Fluorouracil—colon cancer	0.000566	0.00244	CcSEcCtD
Montelukast—Nausea—Irinotecan—colon cancer	0.00056	0.00241	CcSEcCtD
Montelukast—Dyspepsia—Capecitabine—colon cancer	0.000556	0.00239	CcSEcCtD
Montelukast—Gastrointestinal disorder—Capecitabine—colon cancer	0.000545	0.00235	CcSEcCtD
Montelukast—Fatigue—Capecitabine—colon cancer	0.000544	0.00234	CcSEcCtD
Montelukast—Pain—Capecitabine—colon cancer	0.00054	0.00232	CcSEcCtD
Montelukast—Nausea—Fluorouracil—colon cancer	0.000537	0.00231	CcSEcCtD
Montelukast—Gastrointestinal pain—Capecitabine—colon cancer	0.000516	0.00222	CcSEcCtD
Montelukast—Cough—Methotrexate—colon cancer	0.000502	0.00216	CcSEcCtD
Montelukast—Urticaria—Capecitabine—colon cancer	0.000501	0.00216	CcSEcCtD
Montelukast—Body temperature increased—Capecitabine—colon cancer	0.000499	0.00215	CcSEcCtD
Montelukast—Abdominal pain—Capecitabine—colon cancer	0.000499	0.00215	CcSEcCtD
Montelukast—Convulsion—Methotrexate—colon cancer	0.000499	0.00215	CcSEcCtD
Montelukast—Arthralgia—Methotrexate—colon cancer	0.00049	0.00211	CcSEcCtD
Montelukast—Myalgia—Methotrexate—colon cancer	0.00049	0.00211	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000487	0.0021	CcSEcCtD
Montelukast—Anaphylactic shock—Methotrexate—colon cancer	0.00047	0.00202	CcSEcCtD
Montelukast—Infection—Methotrexate—colon cancer	0.000467	0.00201	CcSEcCtD
Montelukast—Hypersensitivity—Capecitabine—colon cancer	0.000465	0.002	CcSEcCtD
Montelukast—Nervous system disorder—Methotrexate—colon cancer	0.000461	0.00198	CcSEcCtD
Montelukast—Thrombocytopenia—Methotrexate—colon cancer	0.00046	0.00198	CcSEcCtD
Montelukast—Skin disorder—Methotrexate—colon cancer	0.000456	0.00197	CcSEcCtD
Montelukast—Asthenia—Capecitabine—colon cancer	0.000453	0.00195	CcSEcCtD
Montelukast—Pruritus—Capecitabine—colon cancer	0.000447	0.00192	CcSEcCtD
Montelukast—Diarrhoea—Capecitabine—colon cancer	0.000432	0.00186	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000428	0.00184	CcSEcCtD
Montelukast—Insomnia—Methotrexate—colon cancer	0.000425	0.00183	CcSEcCtD
Montelukast—Paraesthesia—Methotrexate—colon cancer	0.000422	0.00182	CcSEcCtD
Montelukast—Somnolence—Methotrexate—colon cancer	0.000418	0.0018	CcSEcCtD
Montelukast—Dizziness—Capecitabine—colon cancer	0.000417	0.0018	CcSEcCtD
Montelukast—Dyspepsia—Methotrexate—colon cancer	0.000414	0.00178	CcSEcCtD
Montelukast—Gastrointestinal disorder—Methotrexate—colon cancer	0.000406	0.00175	CcSEcCtD
Montelukast—Fatigue—Methotrexate—colon cancer	0.000405	0.00174	CcSEcCtD
Montelukast—Pain—Methotrexate—colon cancer	0.000402	0.00173	CcSEcCtD
Montelukast—Vomiting—Capecitabine—colon cancer	0.000401	0.00173	CcSEcCtD
Montelukast—Rash—Capecitabine—colon cancer	0.000398	0.00171	CcSEcCtD
Montelukast—Dermatitis—Capecitabine—colon cancer	0.000398	0.00171	CcSEcCtD
Montelukast—Headache—Capecitabine—colon cancer	0.000395	0.0017	CcSEcCtD
Montelukast—Gastrointestinal pain—Methotrexate—colon cancer	0.000384	0.00165	CcSEcCtD
Montelukast—Nausea—Capecitabine—colon cancer	0.000375	0.00161	CcSEcCtD
Montelukast—Urticaria—Methotrexate—colon cancer	0.000373	0.00161	CcSEcCtD
Montelukast—Body temperature increased—Methotrexate—colon cancer	0.000371	0.0016	CcSEcCtD
Montelukast—Abdominal pain—Methotrexate—colon cancer	0.000371	0.0016	CcSEcCtD
Montelukast—Hypersensitivity—Methotrexate—colon cancer	0.000346	0.00149	CcSEcCtD
Montelukast—Asthenia—Methotrexate—colon cancer	0.000337	0.00145	CcSEcCtD
Montelukast—Pruritus—Methotrexate—colon cancer	0.000332	0.00143	CcSEcCtD
Montelukast—Diarrhoea—Methotrexate—colon cancer	0.000322	0.00138	CcSEcCtD
Montelukast—Dizziness—Methotrexate—colon cancer	0.000311	0.00134	CcSEcCtD
Montelukast—Vomiting—Methotrexate—colon cancer	0.000299	0.00129	CcSEcCtD
Montelukast—Rash—Methotrexate—colon cancer	0.000296	0.00128	CcSEcCtD
Montelukast—Dermatitis—Methotrexate—colon cancer	0.000296	0.00127	CcSEcCtD
Montelukast—Headache—Methotrexate—colon cancer	0.000294	0.00127	CcSEcCtD
Montelukast—Nausea—Methotrexate—colon cancer	0.000279	0.0012	CcSEcCtD
